Login
Super Investors BRAIDWELL LP
B

BRAIDWELL LP

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$2.41B
Positions
88
Quarter ended
September 30, 2026
Filed
November 16, 2026

Reported portfolio value by quarter (16 quarters reported)

$3.53B $2.41B
Q4 22 Q4 23 Q4 24 Q4 25 Q3 26

$2.98B in Q4 2022 → $2.41B now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
Kodiak Sciences Inc 4.3% Trimmed 39% 1,085,743 $103M
Caris Life Sciences Inc 3.5% Trimmed 67% 2,746,688 $84.1M
Edgewise Therapeutics Inc 3.5% Added 3.6% 2,069,091 $84M
AH Alphatec Hldgs Inc 3.1% Added 11% 7,228,839 $74.6M
Irhythm Holdings Inc 3.0% Trimmed 2.1% 640,562 $72.8M
AH Alphatec Hldgs Inc 2.9% Unchanged 69,121,000 $69.3M
Hinge Health Inc 2.6% Trimmed 51% 655,306 $63.7M
Spyre Therapeutics Inc 2.6% Trimmed 19% 713,957 $63.6M
Xenon Pharmaceuticals Inc 2.6% Added 51% 1,708,435 $63.5M
Neogenomics Inc 2.6% Trimmed 32% 3,348,502 $61.5M
Glaukos Corp 2.3% Trimmed 42% 343,873 $56.5M
VT Vera Therapeutics Inc 2.3% Added 206% 1,726,693 $55.8M
Transmedics Group Inc 2.3% Added 7.3% 654,178 $54.6M
Intuitive Surgical Inc 2.1% Added 80% 125,957 $51.2M
AH Aveanna Healthcare Hldgs Inc 2.0% Added 26% 3,870,106 $48M
Neurocrine Biosciences Inc 2.0% Added 0.1% 336,571 $47.7M
Dianthus Therapeutics Inc 1.9% Trimmed 13% 518,398 $45.6M
BH Brightspring Health Svcs Inc 1.9% Added 34% 802,472 $45.5M
Generate Biomedicines Inc 1.8% Trimmed 9.8% 2,962,249 $44.5M
ML Maravai Lifesciences Hldgs I 1.7% Trimmed 37% 5,503,086 $42.2M
Krystal Biotech Inc 1.6% Trimmed 12% 114,077 $37.9M
AH Acadia Healthcare Company In 1.5% Added 19% 1,352,693 $37.2M
Damora Therapeutics Inc 1.5% New 1,747,659 $37.2M
Alamar Biosciences Inc 1.5% Unchanged 1,083,983 $36.9M
Kymera Therapeutics Inc 1.4% Trimmed 21% 300,569 $33.6M
Nuvectis Pharma Inc 1.4% New 1,573,823 $33.2M
Climb Bio Inc 1.4% Added 2.4% 2,863,350 $32.8M
IM Inspire Med Sys Inc 1.3% Trimmed 31% 464,470 $32.2M
DD Danaher Corp Del 1.3% Trimmed 6.1% 141,504 $31.4M
Maze Therapeutics Inc 1.3% Added 0.9% 1,149,735 $31.2M
Humana Inc 1.3% Trimmed 29% 81,399 $31.1M
Monte Rosa Therapeutics Inc 1.3% Added 3.0% 2,526,009 $30.1M
TP Teva Pharmaceutical Inds Ltd 1.2% New 753,537 $29.8M
Thermo Fisher Scientific Inc 1.2% Trimmed 53% 41,675 $28.1M
IH Immunocore Hldgs PLC 1.1% Added 74% 906,115 $27.4M
Nektar Therapeutics 1.1% Trimmed 6.3% 443,591 $26.9M
Oruka Therapeutics Inc 1.1% Added 15% 319,679 $26.6M
Boston Scientific Corp 1.1% Unchanged 587,567 $25.6M
Natera Inc 1.0% Trimmed 25% 59,900 $24.8M
Evolus Inc 1.0% Trimmed 2.3% 3,084,022 $24.7M
Avalo Therapeutics Inc 1.0% Trimmed 1.2% 1,609,392 $24.7M
Orthopediatrics Corp 1.0% Unchanged 1,100,370 $24.5M
Rhythm Pharmaceuticals Inc 1.0% Trimmed 33% 255,828 $24.4M
Bright Minds Biosciences Inc 1.0% Unchanged 483,822 $24.1M
Mbx Biosciences Inc 1.0% Trimmed 44% 398,951 $23.4M
Corvus Pharmaceuticals Inc 0.9% Trimmed 9.2% 1,931,402 $22.2M
Repligen Corp 0.9% Trimmed 37% 111,500 $21.4M
AP Avalyn Pharmaceuticals Inc 0.9% Trimmed 7.1% 744,460 $21.2M
Gh Research PLC 0.9% Added 336% 902,815 $21.2M
Guardant Health Inc 0.9% Trimmed 20% 117,910 $21M
Nurix Therapeutics Inc 0.9% Trimmed 32% 871,104 $20.7M
Castle Biosciences Inc 0.7% New 502,508 $17.9M
Neogenomics Inc 0.7% Unchanged 18,011,000 $16.9M
Ovid Therapeutics Inc 0.7% Added 11% 6,582,421 $16.4M
Stryker Corporation 0.6% New 49,560 $13.6M
Oric Pharmaceuticals Inc 0.6% Trimmed 18% 990,959 $13.3M
Septerna Inc 0.5% New 328,240 $12.8M
Cogent Biosciences Inc 0.5% New 400,913 $12.8M
Adlai Nortye Group Ltd 0.5% Unchanged 795,214 $12.7M
Lifestance Health Group Inc 0.5% New 975,385 $11.7M

Showing top 60 of 88 positions.

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q3 2026

quarter ended September 30, 2026 · filed November 16, 2026

Company Action Shares changed Value of change % of portfolio
Caris Life Sciences Inc Trimmed −5,509,344 −$169M 3.5%
Kodiak Sciences Inc Trimmed −701,575 −$66.5M 4.3%
Hinge Health Inc Trimmed −674,821 −$65.6M 2.6%
Damora Therapeutics Inc Exited −1,620,377 −$42.1M —
Acadia Pharmaceuticals Inc Exited −1,646,399 −$41.7M —
Glaukos Corp Trimmed −248,054 −$40.7M 2.3%
VT Vera Therapeutics Inc Added +1,161,969 +$37.5M 2.3%
Damora Therapeutics Inc New +1,747,659 +$37.2M 1.5%
Caredx Inc Exited −1,220,602 −$34.8M —
Nuvectis Pharma Inc New +1,573,823 +$33.2M 1.4%

Showing the 10 largest of 88 changes.

Q2 2026

quarter ended June 30, 2026 · filed August 14, 2026

Company Action Shares changed Value of change % of portfolio
Guardant Health Inc Exited −60,954,000 −$103M —
Repligen Corp Trimmed −85,000,000 −$87.4M 0.6%
Centessa Pharmaceuticals PLC Exited −1,986,768 −$78.9M —
Neogenomics Inc Trimmed −82,370,000 −$77.2M 0.6%
Nuvalent Inc Exited −700,429 −$71.8M —
Cg Oncology Inc Exited −984,783 −$66.7M —
Argenx Se Trimmed −67,232 −$62.4M 0.6%
Neurocrine Biosciences Inc Trimmed −315,950 −$53.2M 2.1%
Guardant Health Inc Trimmed −351,862 −$52.8M 0.8%
Humana Inc New +114,500 +$45.5M 1.7%

Showing the 10 largest of 107 changes.

Q1 2026

quarter ended March 31, 2026 · filed May 15, 2026

Company Action Shares changed Value of change % of portfolio
Edgewise Therapeutics Inc Trimmed −2,863,248 −$90.2M 2.5%
Guardant Health Inc Trimmed −43,900,000 −$73.9M 3.4%
Irhythm Technologies Inc Exited −52,000,000 −$72.8M —
AH Alphatec Hldgs Inc New +61,621,000 +$63.4M 2.1%
Cg Oncology Inc Trimmed −885,788 −$60M 2.2%
Align Technology Inc Exited −381,004 −$59.5M —
Ironwood Pharmaceuticals Inc Exited −53,405,000 −$50.5M —
Irhythm Holdings Inc Added +392,847 +$46.4M 2.4%
Guardant Health Inc New +499,712 +$46.2M 1.5%
Generate Biomedicines Inc New +3,592,999 +$44.9M 1.5%

Showing the 10 largest of 98 changes.

Q4 2025

quarter ended December 31, 2025 · filed February 17, 2026

Company Action Shares changed Value of change % of portfolio
Guardant Health Inc Trimmed −114,600,000 −$210M 6.2%
Novocure Ltd Exited −211,364,000 −$210M —
Xenon Pharmaceuticals Inc Trimmed −1,779,953 −$79.8M 2.6%
Krystal Biotech Inc Trimmed −318,300 −$78.5M 1.6%
Apogee Therapeutics Inc Trimmed −863,678 −$65.2M 1.4%
Cg Oncology Inc Trimmed −1,412,746 −$58.7M 2.5%
Kodiak Sciences Inc New +2,072,788 +$58M 1.9%
Centessa Pharmaceuticals PLC New +2,188,320 +$54.7M 1.8%
BH Brightspring Health Svcs Inc New +1,195,786 +$44.8M 1.4%
Danaher Corporation Trimmed −191,112 −$43.7M 0.9%

Showing the 10 largest of 88 changes.

Q3 2025

quarter ended September 30, 2025 · filed November 14, 2025

Company Action Shares changed Value of change % of portfolio
Argenx Se Trimmed −118,400 −$87.3M 1.7%
Soleno Therapeutics Inc New +1,281,989 +$86.7M 2.6%
Novocure Ltd Added +70,530,000 +$70.1M 6.2%
Acadia Pharmaceuticals Inc New +2,378,655 +$50.8M 1.5%
AB Adaptive Biotechnologies Cor Trimmed −3,127,093 −$46.8M 0.3%
Hinge Health Inc New +910,476 +$44.7M 1.3%
Guardant Health Inc Exited −837,800 −$43.6M —
Neurocrine Biosciences Inc Trimmed −280,143 −$39.3M 3.7%
Krystal Biotech Inc Trimmed −207,410 −$36.6M 2.7%
Cvs Health Corp New +438,600 +$33.1M 1.0%

Showing the 10 largest of 64 changes.

Q2 2025

quarter ended June 30, 2025 · filed August 14, 2025

Company Action Shares changed Value of change % of portfolio
Caris Life Sciences Inc New +7,316,142 +$195M 6.7%
Transmedics Group Inc Trimmed −599,836 −$80.4M 1.2%
Bridgebio Pharma Inc Exited −62,838,000 −$72M —
Krystal Biotech Inc Added +327,067 +$45M 3.4%
Bridgebio Pharma Inc Exited −48,594,000 −$43.8M —
Irhythm Technologies Inc Trimmed −256,362 −$39.5M 1.6%
Blueprint Medicines Corp Exited −439,968 −$38.9M —
Edgewise Therapeutics Inc Added +2,752,023 +$36.1M 2.3%
Karyopharm Therapeutics Inc New +48,482,000 +$35.5M 1.2%
IM Inspire Med Sys Inc Added +220,000 +$28.5M 2.3%

Showing the 10 largest of 56 changes.

Q1 2025

quarter ended March 31, 2025 · filed May 15, 2025

Company Action Shares changed Value of change % of portfolio
Guardant Health Inc New +219,454,000 +$227M 8.0%
Guardant Health Inc Exited −268,252,000 −$226M —
N Nuvasive Inc Exited −114,206,000 −$113M —
Irhythm Technologies Inc New +86,000,000 +$89.7M 3.2%
Bridgebio Pharma Inc Trimmed −78,000,000 −$89.4M 2.5%
Guardant Health Inc Trimmed −1,520,604 −$64.8M 2.0%
Danaher Corporation New +309,339 +$63.4M 2.2%
AH Alphatec Hldgs Inc Trimmed −52,399,000 −$52.2M 0.2%
Dexcom Inc Trimmed −57,250,000 −$51.3M 0.8%
Argenx Se Added +80,083 +$47.4M 3.3%

Showing the 10 largest of 72 changes.

Q4 2024

quarter ended December 31, 2024 · filed February 14, 2025

Company Action Shares changed Value of change % of portfolio
Repligen Corp New +112,000,000 +$115M 3.4%
Insulet Corp Exited −63,800,000 −$76.4M —
Transmedics Group Inc New +922,100 +$57.5M 1.7%
Travere Therapeutics Inc Exited −56,031,000 −$53.5M —
Dexcom Inc Trimmed −55,000,000 −$53.1M 0.5%
Legend Biotech Corp Added +1,436,400 +$46.7M 2.9%
Thermo Fisher Scientific Inc New +89,754 +$46.7M 1.4%
Penumbra Inc Trimmed −177,600 −$42.2M 1.3%
Madrigal Pharmaceuticals Inc Exited −183,818 −$39M —
Apellis Pharmaceuticals Inc Trimmed −1,026,317 −$32.7M 2.0%

Showing the 10 largest of 76 changes.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support